The Qool Therapeutics Team

Our management team, board of directors and clinical advisors are a select group of physicians, specialists and experts in the field of therapeutic hypothermia and medical devices.

 

Management Team

Beverly Huss, M.S. – President and CEO

Beverly Huss joined Qool Therapeutics as President and CEO in September 2013.  Previously, Beverly was President and CEO of Vibrynt, Inc. a company that developed a novel minimally invasive therapeutic device for treatment of morbid obesity.  Prior to this, Beverly was with Santa Clara, California-based Guidant since 1986, fulfilling a variety of executive roles within the company’s various medical device divisions. She managed the worldwide Endovascular Solutions business as President and quadrupled worldwide revenues to $150 million for the carotid and peripheral vascular business in four years.

Prior to this Beverly held several executive level positions as Vice President of Guidant’s Canada and Latin America operations, Vice President of Vascular Intervention Global Marketing and Vice President of the Stent Business Unit where she built the company’s coronary stent business, a market leader for 27 of 28 quarters. Earlier in her career, Beverly held engineering positions at both Honeywell Defense Systems Division and Jones and Laughlin Steel. Additionally, she served as chairman of the Silicon Valley American Heart Association and as a senior advisor to Pervasis Therapeutics, a Cambridge, MA based cell therapy company.

Beverly holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois. Beverly has several patents to her credit in the cardiovascular and obesity medical device areas. Beverly serves on the board of Surefire Medical, Ciel Medical, and the University of Illinois Material Science and Engineering steering Committee and Biomedical Engineering Steering Committee. She previously served on the boards of Ulthera, Dade Behring, Inc., Wright Medical Inc., and Artes Medical. Ms. Huss was the recipient of the 2013 University Of Illinois College Of Engineering Alumni Award for distinguished leadership in the medical device industry.

Amir Belson, M.D. – Founder and Chief Technology Officer

Amir is the founder of Qool Therapeutics and is a serial entrepreneur.  Prior to founding the company, Amir conceived of and started ZipLine Medical, was the founder of Neoguide Systems, a company that developed platform technology for minimally invasive surgical procedures that was later acquired by Intuitive Surgical in 2009. He is also the founder of Vascular Pathways, a company that developed an FDA cleared vascular intervention technology that has been chosen as one of the 10 best inventions of 2009 by Popular Science magazine and was acquired by C.R Bard in 2015. In addition, Amir founded Radiaction, a radiation protection medical device company and VasoStitch, which develops large vessel access and closure technology.

Amir graduated cum laude from the school of medicine of the Technion, Israel Institute of Technology, in Haifa, Israel. He did his pediatric residency at Dana Children’s Hospital in Tel Aviv and his pediatric nephrology fellowship at Lucile Packard Children’s Hospital at Stanford. He also served several years as a flight surgeon in Israel’s air force rescue unit before moving to the US for a three year Pediatric Nephrology fellowship at Stanford University Medical Center. Belson also spent one year as a research fellow with the Biomedical Technology Innovation Program at Stanford.

Board of Directors

Beverly Huss, M.S.

President and CEO

Amir Belson, M.D.

Founder and Chief Technology Officer

Jim Dennis

Jim Dennis is the President of his own consulting company, Rocky Mountain Med Tech, and has over 30 years’ experience in the medical device industry.  Prior to starting his own consulting business Mr. Dennis served as Worldwide President for Johnson and Johnson’s Biosense Webster Division.  Earlier in his career he served as President of the Cardiac Rhythm Management Division for St. Jude Medical, President and CEO of Telectronics Pacing Systems, and Vice President of Operations for Nellcor Inc.  His medical device career began with IVAC Corporation, a pioneer in the development of IV instrumentation and electronic vital signs devices.

In addition to Qool Therapeutics, he serves on the Boards of Confluent Development, a real estate development company, where he is Chairman, and Akonia Holographics, and early stage Development Company specializing in storage technology and AR/VR displays.   Mr. Dennis received a B.A in Business Administration and an M.B. A. in Finance from National University in San Diego, California.

Ronald Dieck

Ronald Dieck was a founder, President and CEO of Tenaxis Medical, recently acquired by The Medicines Company.   In addition to Tenaxis Medical, he was a founder of PneumRx, Magic Venture Capital, Spinal Concepts and founder, President and CEO of Micro Interventional Systems.  He has held executive positions at American Hospital Supply, Baxter Healthcare, Wright Medical and American Medical Electronics.

Mr. Dieck has additionally served as a Director with Interface Catheter Solutions and the Asian American Institute for Research and Education.  He has extensive experience in general management, research and development, marketing, manufacturing and private equity financing.

Mr. Dieck holds a B.A. in chemistry from Ripon College and a Ph.D. in Chemistry from Arizona State University.  He is the inventor of over fifty United States Patents and has authored over forty technical papers.

Frederic Moll, M.D.

Frederic H. Moll, M.D. serves as Chairman and Chief Executive Office of Auris Surgical Robotics, a private company located in San Carlos, California. Dr. Moll is a distinguished medical device entrepreneur and has more than 20 years of medical device and high technology experience.

In 1995, Dr. Moll founded Intuitive Surgical, Inc. (Nasdaq:ISRG), serving as the company’s first CEO. Prior to Intuitive Surgical, Dr. Moll co-founded Origin Medsystems, Inc. which was acquired by Eli Lilly in 1992 and later became an operating company within the Guidant Corporation. Before co-founding Origin Medsystems, Dr. Moll founded Endotherapeutics Corporation, a pioneering company in laparoscopic surgical technology. Endotherapeutics was acquired by U.S. Surgical in 1992. Dr. Moll also serves on the Boards of several Silicon Valley healthcare companies.

Dr. Moll is a distinguished speaker and lecturer and is the author of numerous scientific articles. Dr. Moll received an M.D. from the University of Washington’s School of Medicine, an M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley.

Clinical Advisors

Michael Dae, M.D., MBA

UCSF Professor of Radiology and Medicine
Former Chief Medical Officer, Radiant Medical

W. Dalton Dietrich, Ph.D.

University of Miami
Chair in Neurosurgery, Professor of Neurological Surgery, Neurology and Cell Biology & Anatomy

Michael F. Dillingham, M.D.

SOAR  Sports, Orthopedic Surgery and Rehabilitation Medicine Associates
San Francisco Giants, Team Physician

Elazer Edelman, M.D., Ph.D.

MIT, Professor of Health Sciences and Technology, Professor of Medicine
Harvard Medical School Director, Director Harvard-MIT Biomedical Engineering Center

Carmelo Graffagnino, M.D.

Duke University
Professor of Neurology, Division Chief, Neurocritical Care

Jim Heslin, JD

Patent counsel
Wilson, Sonsini, Goodrich and Rosati

Thomas Krummel, M.D.

Stanford University
Former Surgeon in Chief, Co-Director, Biodesign Program

Steve  Ruoss, M.D.

Stanford University
Co-Chief, Pulmonary and Critical Care Medicine

Gary Steinberg, M.D., Ph.D.

Stanford University
Professor of Neurosurgery and  Neurosciences, Chairman, Dept. of Neurosurgery, Co-Director, Stroke Center

Gregg Stone, M.D.

Columbia University
Director of Cardiovascular Research and Education Medical Center / New York-Presbyterian Hospital

Kristine Tatsutani, Ph.D.

Serial entrepreneur, cryobiologist, medical device executive venture backed and Fortune 500 companies; former Chief Science Officer Zeltiq

Renu Virmani, M.D.

Georgetown University
Founder and Director of CVPath Institute, Clinical Professor, Department of Pathology

Paul Yock, M.D.

Stanford University, Professor of Medicine
Founder, Director, Biodesign Program